Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...

Flu, Covid, RSV and HMPV rising in NJ? Here's what to know about human metapneumovirus symptoms and why there may be no treatment. Is it serious?

Based on two test negative case control studies in immunocompromised adults, RSV vaccination was associated with a 70% reduction in RSV-associated hospitalization (95% CI: 66–73%). Indirect evidence ...

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or ...

A wave of Israel-Palestine protests across cities and college campuses has triggered a series of mask ban laws. Backers say they’re about public safety, but those on the ground argue they’re coded ...

Immunocompromised status remains a significant risk factor for in-hospital mortality in COVID-19, particularly among patients with pneumonia.

New guidance backs seasonal COVID-19 vaccination in immunocompromised patients. Read more on timing and risk groups.

Pritelivir, an investigational antiviral drug for herpes simplex virus, demonstrated “superior efficacy” in healing lesions ...